These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18195289)

  • 21. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.
    Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M
    Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
    Kang S; Yang Y; Li CJ; Gao R
    Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the standard of care?
    Bertoldi EG; Polanczyk CA; Cunha V; Ziegelmann PK; Beck-da-Silva L; Rohde LE
    J Card Fail; 2011 Oct; 17(10):860-6. PubMed ID: 21962425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators.
    Ermis C; Zhu AX; Vanheel L; Lemke MJ; Sakaguchi S; Lurie KG; Lu F; Lin J; Benditt DG
    Am J Cardiol; 2005 Jul; 96(2):233-8. PubMed ID: 16018849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of early implantation of cardioverter defibrillator for postoperative ventricular tachyarrhythmia.
    Bolad I; MacLellan C; Karanam S; Parrella F; Michaud G; D'Agostino R; Shahian D; John R; Martin D
    Am J Cardiol; 2004 Aug; 94(3):376-8. PubMed ID: 15276111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early and late survival after surgical revascularization for ischemic ventricular fibrillation/tachycardia.
    Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L
    Ann Thorac Surg; 2008 Apr; 85(4):1278-81. PubMed ID: 18355509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
    J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fish Oil Supplementation does not Reduce Risks of Gestational Diabetes Mellitus, Pregnancy-Induced Hypertension, or Pre-Eclampsia: A Meta-Analysis of Randomized Controlled Trials.
    Chen B; Ji X; Zhang L; Hou Z; Li C; Tong Y
    Med Sci Monit; 2015 Aug; 21():2322-30. PubMed ID: 26256041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defibrillation threshold testing does not predict clinical outcomes during long-term follow-up: a meta-analysis.
    Stavrakis S; Patel NH; Reynolds DW
    Pacing Clin Electrophysiol; 2013 Nov; 36(11):1402-8. PubMed ID: 23875736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials.
    Barakat AF; Saad M; Elgendy AY; Mentias A; Abuzaid A; Mahmoud AN; Elgendy IY
    BMJ Open; 2017 Jun; 7(6):e016352. PubMed ID: 28637742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity in randomized controlled trials of long chain (fish) omega-3 fatty acids in restenosis, secondary prevention and ventricular arrhythmias.
    Jenkins DJ; Josse AR; Dorian P; Burr ML; LaBelle Trangmar R; Kendall CW; Cunnane SC
    J Am Coll Nutr; 2008 Jun; 27(3):367-78. PubMed ID: 18838524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should patients with cardiovascular disease take fish oil?
    Nair GM; Connolly SJ
    CMAJ; 2008 Jan; 178(2):181-2. PubMed ID: 18195293
    [No Abstract]   [Full Text] [Related]  

  • 37. Fish oil and atrial fibrillation after cardiac surgery: a meta-analysis of randomized controlled trials.
    Xin W; Wei W; Lin Z; Zhang X; Yang H; Zhang T; Li B; Mi S
    PLoS One; 2013; 8(9):e72913. PubMed ID: 24039820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias? A meta-analysis of randomized trials.
    Khoueiry G; Abi Rafeh N; Sullivan E; Saiful F; Jaffery Z; Kenigsberg DN; Krishnan SC; Khanal S; Bekheit S; Kowalski M
    Heart Lung; 2013; 42(4):251-6. PubMed ID: 23714269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials.
    Romero J; Chaudhary R; Garg J; Lupercio F; Shah N; Gupta R; Nazir T; Bozorgnia B; Natale A; Di Biase L
    J Interv Card Electrophysiol; 2017 Sep; 49(3):263-270. PubMed ID: 28674918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selenium supplementation for sepsis: a meta-analysis of randomized controlled trials.
    Kong Z; Wang F; Ji S; Deng X; Xia Z
    Am J Emerg Med; 2013 Aug; 31(8):1170-5. PubMed ID: 23791608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.